Description
i-CRT3 is a small cell-permeable oxazole derivative that acts as an inhibitor of both Wnt and β-catenin-responsive transcription.
i-CRT3 is a small cell-permeable oxazole derivative that acts as an inhibitor of both Wnt and β-catenin-responsive transcription.
Alternate Name/Synonyms: 2-[[[2-(4-ethylphenyl)-5-methyl-4-oxazolyl]methyl]thio]-N-(2-phenylethyl)acetamide, iCRT3
Appearance: White to off-white solid
Formulation:
CAS Number: 901751-47-1
Structure Available?: Yes
Peptide sequence: N/A
Salt Form: No
Molecular Formula: C₂₃H₂₆N₂O₂S
Molecular Weight: 394.53
Cell-Permeable?: True
Purity: ≥98% by HPLC
Solubilities: >30 mg/ml in DMSO
Handling: Do not take internally. Wear gloves and mask when handling the product! Avoid contact by all modes of exposure.
Country of Origin: USA
Tag Line: A β-Catenin/Tcf Inhibitor
MDL Number: MFCD14766288
PubChem CID: 6622273
SMILES: CCC1=CC=C(C=C1)C2=NC(=C(O2)C)CSCC(=O)NCCC3=CC=CC=C3
InChi: InChI=1S/C23H26N2O2S/c1-3-18-9-11-20(12-10-18)23-25-21(17(2)27-23)15-28-16-22(26)24-14-13-19-7-5-4-6-8-19/h4-12H,3,13-16H2,1-2H3,(H,24,26)
InChi Key: QTDYVSIBWGVBKU-UHFFFAOYSA-N
Additional Information
Storage Condition: |
-20ºC |
Shipping Condition: |
Gel Pack |
Shelf Life: |
36 months |